ArticleJournal for immunotherapy of cancer2021

Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection.

Erin M Hall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.